Rheumatology

Solid organ malignancy

Questions discussed in this category

Would you continue TNFi for inflammatory arthritis if the patient develops a solid organ malignancy while on that therapy?

1 Answer available

What is the safest approach to treating refractory RA in the setting of an active solid organ malignancy?

Prior therapies include MTX, abatacept, rituximab

1 Answer available

Related Topics in Rheumatology